Loading...
Chemical structure of Palazestrant

GC71052

Palazestrant

Also known as (1R,3R)-2-(2-fluoro-2-methylpropyl)-3-methyl-1-[4-(1-propylazetidin-3-yl)oxyphenyl]-1,3,4,9-tetrahydropyrido[3,4-b]indole

Palazestrant is an antiestrogen and antineoplastic agent

ChemicalCAS2092925-89-6MW449.6FormulaC28H36FN3O
CAS number
2092925-89-6
Molecular weight
449.6
Formula
C28H36FN3O
Solubility
DMSO ： 22·22 mg/mL (49·42 mM; ultrasonic and adjust pH to 3 with 1M HCl; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
InChIKey
LBSFUBLFDCAEKV-XHCCPWGMSA-N
Catalogue number
GC71052
Brand
GLPBIO
Computed properties PubChem CID 135351887 · XLogP 5.8 · TPSA 31.5 Ų · H-bond donors 1
XLogP
5.8
TPSA
31.5 Ų
H-bond donors
1
H-bond acceptors
4
Rotatable bonds
7
Heavy atoms
33

SMILES CCCN1CC(C1)OC2=CC=C(C=C2)[C@@H]3C4=C(C[C@H](N3CC(C)(C)F)C)C5=CC=CC=C5N4

Computed descriptors from PubChem (CID 135351887), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.